Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression

被引:37
|
作者
Ko, Yong-Hyun [1 ]
Kim, Seon-Kyung [1 ]
Lee, Seok-Yong [1 ]
Jang, Choon-Gon [1 ]
机构
[1] Sungkyunkwan Univ, Sch Pharm, Dept Pharmacol, Suwon 16419, South Korea
基金
新加坡国家研究基金会;
关键词
Flavonoids; Emotional disorders; Depression; Anxiety; Therapeutic effects; Mechanisms of action; UNPREDICTABLE MILD STRESS; INDUCED OXIDATIVE STRESS; RAT MODEL; ANTIDEPRESSANT DRUGS; MOLECULAR-MECHANISMS; ANTIOXIDANT ACTIVITY; SIGNAL PATHWAY; NF-B; INFLAMMATION; BEHAVIOR;
D O I
10.1007/s12272-020-01292-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Emotional disorders such as anxiety and depression are widespread psychological diseases that affect up to 20% of the world's population. There are many approaches to the discovery of novel agents for the treatment of depressive- and anxiety-like symptoms. However, the efficacy of existing drugs for emotional disorders is only exerted after a few weeks of treatment and have serious side effects. Due to this, new strategies to find suitable and safe options are being sought by many researchers. Among them, a lot of interest has been attracted by plant-derived natural compounds due to their wide range of beneficial effects for new agent development. Flavonoids are natural polyphenol-like compounds found commonly in plants, fruits, vegetables, and medicinal herbs. A diverse range of flavonoids have been studied to investigate their potential therapeutic activities for the treatment of brain-associated disorders, including anxiety and depression. The main aim of this review is to understand the associations between the various flavonoids and the emotional disorders and discuss the therapeutic effects of these natural compounds that were demonstrated during the conduction of recent studies. The current work shows advances in the latest research of some flavonoids as a potential candidate for the treatment of emotional disorders. We summarize their behavioral, molecular, physiological, and neurochemical effects in various in vitro and in vivo models. Therefore, in the present work, the latest studies were collected on the most important flavonoid compounds and their underlying mechanisms of action in emotion-related disorders were discussed.
引用
收藏
页码:1128 / 1143
页数:16
相关论文
共 50 条
  • [1] Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression
    Yong-Hyun Ko
    Seon-Kyung Kim
    Seok-Yong Lee
    Choon-Gon Jang
    Archives of Pharmacal Research, 2020, 43 : 1128 - 1143
  • [2] MANAGEMENT OF EMOTIONAL DISORDERS ANXIETY AND DEPRESSION IN PATIENTS WITH GASTROINTESTINAL DISEASE
    KASICH, AM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1965, 7 (09): : 542 - &
  • [3] Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
    Holmes, A
    Heilig, M
    Rupniak, NMJ
    Steckler, T
    Griebel, G
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (11) : 580 - 588
  • [4] Neuropeptide receptors: novel therapeutic targets for depression and anxiety disorders
    Chaki, Shigeyuki
    Kanuma, Kosuke
    DRUGS OF THE FUTURE, 2007, 32 (09) : 809 - 822
  • [5] Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
    Devi, Shweta
    Kumar, Vijay
    Singh, Sandeep Kumar
    Dubey, Ashish Kant
    Kim, Jong-Joo
    BIOMEDICINES, 2021, 9 (02) : 1 - 22
  • [6] The screen for child anxiety related emotional disorders (SCARED): Relationship with anxiety and depression in normal children
    Muris, P
    Merckelbach, H
    van Brakel, A
    Mayer, B
    van Dongen, L
    PERSONALITY AND INDIVIDUAL DIFFERENCES, 1998, 24 (04) : 451 - 456
  • [7] The assessment of transdiagnostic dimensions of emotional disorders: Validation of the Multidimensional Emotional Disorders Inventory (MEDI) in adolescents with subthreshold anxiety and depression
    Perez-Esteban, Alfonso
    Diez-Gomez, Adriana
    Perez-Albeniz, Alicia
    Al-Halabi, Susana
    Lucas-Molina, Beatriz
    Debbane, Martin
    Fonseca-Pedrero, Eduardo
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 357 : 138 - 147
  • [8] Depression and anxiety in bariatric surgery candidates
    Kruschewsky, MB
    Azaro, E
    Ettinger, J
    Mello, CAB
    Amaral, P
    Serrano, MO
    dos Santos, MA
    OBESITY SURGERY, 2005, 15 (05) : 748 - 749
  • [9] Depression and anxiety disorders
    Brown, CS
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (02) : 241 - +
  • [10] EMOTIONAL IMAGERY IN PATIENTS WITH ANXIETY DISORDERS: A NEW PARADIGM TO ASSESS THERAPEUTIC RESPONSES
    Hamm, Alfons
    Limberg, Anke
    Richter, Jan
    PSYCHOPHYSIOLOGY, 2012, 49 : S22 - S22